Skip to main content
Universe Pharmaceuticals INC logo

Universe Pharmaceuticals INC — Investor Relations & Filings

Ticker · UPC ISIN · KYG9442G1047 US Manufacturing
Open in API
Filings indexed 99 across all filing types
Latest filing 2025-03-20 Regulatory Filings
Country US United States of America
Listing US UPC

About Universe Pharmaceuticals INC

http://www.universe-pharmacy.com/

Universe Pharmaceuticals INC is a pharmaceutical company specializing in the manufacturing, marketing, sales, and distribution of traditional Chinese medicine (TCM) derivative products. Through its subsidiaries, the company's product portfolio also includes biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements.

Recent filings

Filing Released Lang Actions
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It includes a press release about a share consolidation, but the document length is only 1414 characters, indicating it is a short filing. It does not contain detailed financial statements or substantive financial data. The document is primarily an announcement/report filing rather than a full financial report. According to the rules, short filings that announce or report events without detailed financial data are classified as Regulatory Filings (RNS).
2025-03-20 English
REPORT OF FOREIGN PRIVATE ISSUER
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Universe Pharmaceuticals INC, reporting the results of an Extraordinary General Meeting held in March 2025. The content details shareholder voting results on proposals related to share consolidation and amendments to the memorandum of association. There are no financial statements or detailed financial data presented, nor is this an annual or quarterly report. The document primarily announces the voting results of a shareholder meeting. According to the filing definitions, announcements of shareholder vote results at general meetings fall under Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is just over 5,000 characters but the content is focused on voting results, not a full report or presentation. Therefore, the correct classification is DVA with high confidence.
2025-03-11 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It reports the adjournment of an Extraordinary General Meeting due to lack of quorum and provides details about the rescheduled meeting. The document is short (1786 characters) and does not contain financial statements or detailed financial data. It is an announcement related to a shareholder meeting rather than the meeting materials or voting results. Therefore, it is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2025-03-03 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It includes a press release about a staff determination notice from Nasdaq related to a delayed annual report. The document is short (1479 characters) and primarily serves as a regulatory filing to inform about the status of the annual report, not the annual report itself. There is no substantive financial data or detailed report content. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement.
2025-02-25 English
REPORT OF FOREIGN PRIVATE ISSUER
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Universe Pharmaceuticals INC, with the SEC. It reports the result of an Extraordinary General Meeting held in February 2025, specifically the approval of the indefinite adjournment of the meeting. The document is short (1962 characters) and primarily announces the voting result of a shareholder meeting. There is no detailed financial data, management discussion, or full report content. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), which covers official results from shareholder votes at any general meeting (AGM or EGM).
2025-02-20 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It reports the adjournment of an Extraordinary General Meeting due to lack of quorum and provides details about the rescheduled meeting. The document is short (1803 characters) and does not contain financial statements or detailed financial data. It is an announcement related to a shareholder meeting event rather than the meeting materials or voting results. Therefore, it does not fit categories like AGM Information, Declaration of Voting Results, or Annual Report. Given the nature of the content and the form type, this is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-02-18 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.